A review of vaccinology and <i>ex vivo</i> antigen-loaded dendritic cells: A different approach to infectious disease vaccines. [PDF]
Dillman RO, Nistor GI, Keirstead HS.
europepmc +1 more source
Advanced extracellular vesicle immunotherapy
A diagrammatic depiction of the therapeutic applicability of extracellular vesicles (EVs) in immunotherapy. This review explores the dual roles of tumor‐derived and immune cell‐derived EVs in cancer immunotherapy, discusses recent progress in EV engineering that improve their clinical utility, and evaluates their potential to augment existing ...
Jingjing Zhang +6 more
wiley +1 more source
Messenger RNA vaccines in the prevention of allergic diseases. [PDF]
Li S, Zheng Y, Cheng L.
europepmc +1 more source
Abstract As one of the most important components of foods, animal meat provides a lot of protein, fat, and energy for humans. However, nutrition and health of animals directly affect the healthiness of human, especially antibiotic residues in animals induced by abuse of antibiotics.
Zichao Wang +8 more
wiley +1 more source
Personalized Cancer Vaccines: Current Advances and Emerging Horizons. [PDF]
Lu L, Lu X, Luo W.
europepmc +1 more source
Immune Responses and Protective Efficacy of Nanoemulsion-Adjuvanted Monkeypox Virus Recombinant Vaccines Against Lethal Challenge in Mice. [PDF]
Zhang C +10 more
europepmc +1 more source
Potential of Bovine Herpesvirus Vectors for Recombinant Vaccines. [PDF]
Gokduman EM +4 more
europepmc +1 more source
Advances in Therapeutic Vaccines Against HPV: A Review of Human Clinical Trials. [PDF]
Martín E, Reina G, Carlos S.
europepmc +1 more source
Challenges in the future of cancer screening
Abstract The purpose of cancer screening is to reduce mortality, and ideally incidence, from the cancer screened for. Until recently, cancer screening has been offered to all persons in pre‐defined sex‐ and age‐groups. The exception is lung screening which is targeted to high‐risk individuals.
Elsebeth Lynge +29 more
wiley +1 more source
Protective Efficacy of Two Novel DNA Vaccine Candidates Encoding TgGRA28 and TgGRA83 with an IL-28B Molecular Adjuvant Against Acute and Chronic Toxoplasmosis in Mice. [PDF]
Fang J, Mu J, Li R, Chen J.
europepmc +1 more source

